- Home
- ZCMD vs IBIO Comparison
ZCMD vs IBIO Comparison
Compare ZCMD & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- IBIO
- Stock Information
- Founded
- ZCMD 2012
- IBIO 2008
- Country
- ZCMD China
- IBIO United States
- Employees
- ZCMD N/A
- IBIO N/A
- Industry
- ZCMD Other Consumer Services
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- IBIO Health Care
- Exchange
- ZCMD Nasdaq
- IBIO Nasdaq
- Market Cap
- ZCMD 18.3M
- IBIO 16.4M
- IPO Year
- ZCMD 2020
- IBIO N/A
- Fundamental
- Price
- ZCMD $0.68
- IBIO $1.27
- Analyst Decision
- ZCMD
- IBIO Strong Buy
- Analyst Count
- ZCMD 0
- IBIO 4
- Target Price
- ZCMD N/A
- IBIO $4.50
- AVG Volume (30 Days)
- ZCMD 801.6K
- IBIO 6.8M
- Earning Date
- ZCMD 01-01-0001
- IBIO 10-31-2025
- Dividend Yield
- ZCMD N/A
- IBIO N/A
- EPS Growth
- ZCMD N/A
- IBIO N/A
- EPS
- ZCMD N/A
- IBIO N/A
- Revenue
- ZCMD $13,117,523.00
- IBIO $400,000.00
- Revenue This Year
- ZCMD N/A
- IBIO N/A
- Revenue Next Year
- ZCMD N/A
- IBIO N/A
- P/E Ratio
- ZCMD N/A
- IBIO N/A
- Revenue Growth
- ZCMD N/A
- IBIO 77.78
- 52 Week Low
- ZCMD $0.64
- IBIO $0.56
- 52 Week High
- ZCMD $2.50
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- ZCMD 31.22
- IBIO 68.58
- Support Level
- ZCMD $0.64
- IBIO $1.02
- Resistance Level
- ZCMD $0.83
- IBIO $1.32
- Average True Range (ATR)
- ZCMD 0.07
- IBIO 0.16
- MACD
- ZCMD -0.01
- IBIO 0.04
- Stochastic Oscillator
- ZCMD 16.35
- IBIO 52.05
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.